A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications (NCT06701526)
Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies
🩺 Plain-English Summary (8th-Grade Level)
The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).
Who can join: Review the eligibility criteria below.
Location: Neuropain Medical Center — Fresno, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (28 Sites)
Showing the first 25 of 28 sites.
- Neuropain Medical Center — Fresno, California
- Sunwise Clinical Research, LLC. — Oakland, California
- The Neuron Clinic — San Marcos, California
- St. Joseph's Hospital and Medical Center - Barrow Neurological Institute — Aurora, Colorado
- Advanced Neurology of Colorado, LLC — Longmont, Colorado
- Research of the Rockies — Parker, Colorado
- Hasbani & Hasbani MDs — New Haven, Connecticut
- New England Institute for Neurology and Headache — Stamford, Connecticut
- Brainstorm Research — Miami, Florida
- Premiere Research Institute at Palm Beach Neurology — West Palm Beach, Florida
- PANDA Neurology and Atlanta Headache Specialists — Atlanta, Georgia
- St Luke's Meridian Medical Center — Meridian, Idaho
- Chicago Headache Center & Research Institute — Chicago, Illinois
- Crescent City Headache and Neurology — New Orleans, Louisiana
- Neurology Center of New England P.C. — Foxborough, Massachusetts
- MedVadis Research Corporation — Waltham, Massachusetts
- Mass Institute of Clinical Research — Westborough, Massachusetts
- Memorial Healthcare — Owosso, Michigan
- Albany Medical College — Albany, New York
- Dent Neurosciences Research Center, Inc. — Amherst, New York
- North Suffolk Neurology — Port Jefferson Station, New York
- NeuroScience Research Center, LLC. — Canton, Ohio
- C7 Research — Cleveland, Ohio
- Thomas Jefferson University — Philadelphia, Pennsylvania
- Preferred Primary Care Physicians, Inc. — Pittsburgh, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine
- A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
- Treatment for Migraine and Mood — The Bronx, New York
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
- A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
- Migraine Manager (R01) — Cincinnati, Ohio
- Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey
Explore by condition: All Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.